Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000876638 | SCV001019235 | likely benign | Multiple endocrine neoplasia, type 2 | 2024-03-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005047139 | SCV005674219 | uncertain significance | Hirschsprung disease, susceptibility to, 1; Multiple endocrine neoplasia type 2B; Pheochromocytoma; Familial medullary thyroid carcinoma; Multiple endocrine neoplasia type 2A | 2024-05-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004530852 | SCV004715095 | likely benign | RET-related disorder | 2020-11-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |